Guideline for submitting documentation for the stability of human drugs and biologics. Washington, DC: Center for Drugs and Biologics, Food and Drug Administration, US Department of Health and Human Services; February 1987.
2.
Stability tests on active substances and finished products, note for guidance concerning the application of Section F of Part I of the Annex to Directive 75/318/EEC. III/66/87-EN Rev. 4. Brussels; 1988.
3.
USP Subcommittee on Containers and Materials.Room temperature and controlled room temperature — general notices definitions. Pharmacop Forum. 1988;14: 3895.
4.
GrimmWSchepkyGN. Stability testing in pharmacy — theory and practice. Der Pharmazeut Betrieb. 1980;28: 335–372.
5.
FusariSAHostetlerGL. Reference thermal exposure and performance of room temperature stability studies. Pharmaceut Technol. 1984;8: 48.
6.
Guideline for the format and content of an application summary. Washington, DC: Center for Drugs and Biologies, Food and Drug Administration, US Department of Health and Human Services; June 1985.
7.
Guidance notes for application for product licenses (MAL 2).EEC Guidelines (Directive 75/318/EEC). London: Her Majesty's Stationer; 1987.